Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 12, 2012 - Issue 7
Submit an article Journal homepage
234
Views
23
CrossRef citations to date
0
Altmetric
Theme: Mood Disorders - Review

Finding a biosignature for melancholic depression

Claire VA Day Brain Dynamics Centre, Westmead Millennium Institute and Psychiatry, University of Sydney Medical School-Westmead, Westmead Hospital, Westmead, Sydney, NSW, Australia; Brain Resource Ltd, Stanford University, CA, USA. [email protected]; Brain Resource Ltd, Sydney, NSW, Australia; Brain Resource Ltd, Stanford University, CA, USA. [email protected]
&
Leanne M Williams Brain Dynamics Centre, Westmead Millennium Institute and Psychiatry, University of Sydney Medical School-Westmead, Westmead Hospital, Westmead, Sydney, NSW, Australia; School of Psychiatry and Behavioral Sciences, Stanford University, CA, USA; Brain Dynamics Centre, Westmead Millennium Institute and Psychiatry, University of Sydney Medical School-Westmead, Westmead Hospital, Westmead, Sydney, NSW, Australia; School of Psychiatry and Behavioral Sciences, Stanford University, CA, USA
Pages 835-847 | Published online: 09 Jan 2014

References

  • Kaplan A, Parker G, Fink M et al. Whither melancholia? Psychiatric Times, 8th January (2010).
  • Fitzgerald PB, Mellow TB, Hoy KE et al. A study of intensity dependence of the auditory evoked potential (IDAEP) in medicated melancholic and non-melancholic depression. J. Affect. Disord. 117(3), 212–216 (2009).
  • Bobo WV, Chen H, Trivedi MH et al. Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report. J. Affect. Disord. 133(3), 467–476 (2011).
  • Rush AJ, Warden D, Wisniewski SR et al. STAR*D: revising conventional wisdom. CNS Drugs 23(8), 627–647 (2009).
  • Ohmae S. The debate concerning the classification of depression that predominantly occurred in the United Kingdom from 1926 to 1957: the discovery and reappraisal of ‘mild endogenous depression.’ Seishin Shinkeigaku Zasshi 111(5), 486–501 (2009).
  • Kraepelin E. Quoted in: The History of Mental Symptoms. Berrios GE (Ed.). Cambridge University Press, Cambridge, UK, 311 (1996).
  • Freud S. Mourning and Melancholia. Vintage, London, UK (1917).
  • Gillespie RD. The clinical differentiation of types of depression. Guy. Hosp. Rep. 79, 306–344 (1929).
  • Lewis A. Melancholia: a clinical survey of depressive states. J. Mental Sci. 80, 277–780 (1934).
  • Kuhn R. The treatment of depressive states with G 22355 (imipramine hydrochloride). Am. J. Psychiatry 115(5), 459–464 (1958).
  • Kiloh LG, Garside RF. The independence of neurotic depression and endogenous depression. Br. J. Psychiatry 109, 451–463 (1963).
  • Parker G. Classifying depression: should paradigms lost be regained? Am. J. Psychiatry 157(8), 1195–1203 (2000).
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (3rd Edition). American Psychiatric Association, Washington, DC, USA (1980).
  • Klein DF. Endogenomorphic depression. A conceptual and terminological revision. Arch. Gen. Psychiatry 31(4), 447–454 (1974).
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (2nd Edition). American Psychiatric Association, Washington, DC, USA (1968).
  • Davidson J, Lipper S, Zung WW, Strickland R, Krishnan R, Mahorney S. Validation of four definitions of melancholia by the dexamethasone suppression test. Am. J. Psychiatry 141(10), 1220–1223 (1984).
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (3rd Edition, Rev. Edition). American Psychiatric Association, Washington, DC, USA (1987).
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th Edition). American Psychiatric Association, Washington, DC, USA (1994).
  • Tedlow J, Smith M, Neault N et al. Melancholia and axis II comorbidity. Compr. Psychiatry 43(5), 331–335 (2002).
  • Steinberg M. Interviewers Guide to the Structured Clinical Interview for DSM-IV Dissociative Disorders (SCID-D). American Psychiatric Association, Washington, DC, USA (1994).
  • Sheehan DV, Lecrubier Y, Sheehan KH et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59(Suppl. 20), 22–33; quiz 34 (1998).
  • Parker G, Hadzi-Pavlovic D. Melancholia: A Disorder of Movement and Mood. Cambridge University Press, NY, USA (1996).
  • Widlöcher DJ. Psychomotor retardation: clinical, theoretical, and psychometric aspects. Psychiatr. Clin. North Am. 6(1), 27–40 (1983).
  • McGrath PJ, Khan AY, Trivedi MH et al. Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report. J. Clin. Psychiatry 69(12), 1847–1855 (2008).
  • Alvarez P, Urretavizcaya M, Benlloch L, Vallejo J, Menchón JM. Early- and late-onset depression in the older: no differences found within the melancholic subtype. Int. J. Geriatr. Psychiatry 26(6), 615–621 (2011).
  • Lamers F, de Jonge P, Nolen WA et al. Identifying depressive subtypes in a large cohort study: results from the Netherlands Study of Depression and Anxiety (NESDA). J. Clin. Psychiatry 71(12), 1582–1589 (2010).
  • Kocsis JH, Gelenberg AJ, Rothbaum B et al. Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatment. J. Affect. Disord. 110(1–2), 55–61 (2008).
  • Fink M, Rush AJ, Knapp R et al.; Consortium for Research in ECT (CORE) Study Group. DSM melancholic features are unreliable predictors of ECT response: a CORE publication. J. ECT 23(3), 139–146 (2007).
  • Szádóczky E, Rózsa S, Patten S, Arató M, Füredi J. Lifetime patterns of depressive symptoms in the community and among primary care attenders: an application of grade of membership analysis. J. Affect. Disord. 77(1), 31–39 (2003).
  • Kendler KS. The diagnostic validity of melancholic major depression in a population-based sample of female twins. Arch. Gen. Psychiatry 54(4), 299–304 (1997).
  • Wiethoff K, Bauer M, Baghai TC et al. Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project. J. Clin. Psychiatry 71(8), 1047–1054 (2010).
  • Uher R, Dernovsek MZ, Mors O et al. Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline. J. Affect. Disord. 132(1–2), 112–120 (2011).
  • Quinn C, Harris A, Kemp A. The interdependence of subtype and severity: contributions of clinical and neuropsychological features to melancholia and non-melancholia in an outpatient sample. J. Int. Neuropsychol. Soc. 18(2), 361–369 (2012).
  • Parker G, Snowdon J, Parker K. Modelling late-life depression. Int. J. Geriatr. Psychiatry 18(12), 1102–1109 (2003).
  • Schotte CK, Maes M, Cluydts R, Cosyns P. Cluster analytic validation of the DSM melancholic depression. The threshold model: integration of quantitative and qualitative distinctions between unipolar depressive subtypes. Psychiatry Res. 71(3), 181–195 (1997).
  • Brown GW, Harris TO, Hepworth C. Life events and endogenous depression. A puzzle reexamined. Arch. Gen. Psychiatry 51(7), 525–534 (1994).
  • D’Aquila PS, Newton J, Willner P. Diurnal variation in the effect of chronic mild stress on sucrose intake and preference. Physiol. Behav. 62(2), 421–426 (1997).
  • Shioiri T, Kato T, Murashita J, Yamada N, Takahashi S. Changes in the frequency distribution pattern of body weight in patients with major depression. Acta Psychiatr. Scand. 88(5), 356–360 (1993).
  • Lemke MR, Broderick A, Zeitelberger M, Hartmann W. Motor activity and daily variation of symptom intensity in depressed patients. Neuropsychobiology 36(2), 57–61 (1997).
  • Austin MP, Mitchell P, Hadzi-Pavlovic D et al. Effect of apomorphine on motor and cognitive function in melancholic patients: a preliminary report. Psychiatry Res. 97(2–3), 207–215 (2000).
  • Florio TM, Parker G, Austin MP, Hickie I, Mitchell P, Wilhelm K. Neural network subtyping of depression. Aust. NZ J. Psychiatry 32(5), 687–694 (1998).
  • van Londen L, Goekoop JG, van Kempen GM et al. Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychopharmacology 17(4), 284–292 (1997).
  • Dougherty LR, Klein DN, Olino TM, Dyson M, Rose S. Increased waking salivary cortisol and depression risk in preschoolers: the role of maternal history of melancholic depression and early child temperament. J. Child Psychol. Psychiatry 50(12), 1495–1503 (2009).
  • Khan AY, Carrithers J, Preskorn SH et al. Clinical and demographic factors associated with DSM-IV melancholic depression. Ann. Clin. Psychiatry 18(2), 91–98 (2006).
  • Essex MJ, Shirtcliff EA, Burk LR et al. Influence of early life stress on later hypothalamic–pituitary–adrenal axis functioning and its covariation with mental health symptoms: a study of the allostatic process from childhood into adolescence. Dev. Psychopathol. 23(4), 1039–1058 (2011).
  • Stanghellini G, Raballo A. Exploring the margins of the bipolar spectrum: temperamental features of the Typus melancholicus. J. Affect. Disord. 100(1–3), 13–21 (2007).
  • Rubino IA, Zanasi M, Robone C, Siracusano A. Personality differences between depressed melancholic and non-melancholic inpatients. Aust. NZ J. Psychiatry 43(2), 145–148 (2009).
  • Sun N, Li Y, Cai Y et al. A comparison of melancholic and nonmelancholic recurrent major depression in Han Chinese women. Depress. Anxiety 29(1), 4–9 (2012).
  • Malhi GS, Parker GB, Greenwood J. Structural and functional models of depression: from sub-types to substrates. Acta Psychiatr. Scand. 111(2), 94–105 (2005).
  • Parker G, Wilhelm K, Mitchell P, Roy K, Hadzi-Pavlovic D. Subtyping depression: testing algorithms and identification of a tiered model. J. Nerv. Ment. Dis. 187(10), 610–617 (1999).
  • Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 134(4), 319–329 (1997).
  • Forbes NF, Stewart CA, Matthews K, Reid IC. Chronic mild stress and sucrose consumption: validity as a model of depression. Physiol. Behav. 60(6), 1481–1484 (1996).
  • Overstreet DH. The Flinders sensitive line rats: a genetic animal model of depression. Neurosci. Biobehav. Rev. 17(1), 51–68 (1993).
  • Hill MN, Gorzalka BB. Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression? Behav. Pharmacol. 16(5–6), 333–352 (2005).
  • Ma XC, Jiang D, Jiang WH et al. Social isolation-induced aggression potentiates anxiety and depressive-like behavior in male mice subjected to unpredictable chronic mild stress. PLoS ONE 6(6), e20955 (2011).
  • Harauma A, Moriguchi T. Dietary n-3 fatty acid deficiency in mice enhances anxiety induced by chronic mild stress. Lipids 46(5), 409–416 (2011).
  • Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol. Psychiatry 7(3), 254–275 (2002).
  • Soriano-Mas C, Hernández-Ribas R, Pujol J et al. Cross-sectional and longitudinal assessment of structural brain alterations in melancholic depression. Biol. Psychiatry 69(4), 318–325 (2011).
  • Korgaonkar MS, Grieve SM, Koslow SH, Gabrieli JD, Gordon E, Williams LM. Loss of white matter integrity in major depressive disorder: evidence using tract-based spatial statistical analysis of diffusion tensor imaging. Hum. Brain Mapp. 32(12), 2161–2171 (2011).
  • Pizzagalli DA, Oakes TR, Fox AS. Functional but not structural subgenual prefrontal cortex abnormalities in melancholia. Mol. Psychiatry 9(4), 325, 393–405 (2004).
  • Fernández-Argüelles P, Castro Montaño J, García López O, Cambil Molina T. SPECT study of a group of patients with severe recurrent depression. Actas Luso. Esp. Neurol. Psiquiatr. Cienc. Afines 26(4), 223–232 (1998).
  • Wong ML, Kling MA, Munson PJ et al. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc. Natl Acad. Sci. USA 97(1), 325–330 (2000).
  • Maes M, Meltzer HY, Cosyns P, Suy E, Schotte C. An evaluation of basal hypothalamic–pituitary–thyroid axis function in depression: results of a large-scaled and controlled study. Psychoneuroendocrinology 18(8), 607–620 (1993).
  • Dinan TG, Lavelle E, Scott LV, Newell-Price J, Medbak S, Grossman AB. Desmopressin normalizes the blunted adrenocorticotropin response to corticotropin-releasing hormone in melancholic depression: evidence of enhanced vasopressinergic responsivity. J. Clin. Endocrinol. Metab. 84(6), 2238–2240 (1999).
  • Kelly CB, Cooper SJ. Plasma norepinephrine response to a cold pressor test in subtypes of depressive illness. Psychiatry Res. 81(1), 39–50 (1998).
  • Hadzi-Pavlovic D, Boyce P. Melancholia. Curr. Opin. Psychiatry 25(1), 14–18 (2012).
  • Michopoulos I, Zervas IM, Pantelis C et al. Neuropsychological and hypothalamic–pituitary–axis function in female patients with melancholic and non-melancholic depression. Eur. Arch. Psychiatry Clin. Neurosci. 258(4), 217–225 (2008).
  • Fountoulakis KN, Iacovides A, Gerasimou G et al. The relationship of regional cerebral blood flow with subtypes of major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 28(3), 537–546 (2004).
  • Winograd-Gurvich C, Fitzgerald PB, Georgiou-Karistianis N, Bradshaw JL, White OB. Negative symptoms: a review of schizophrenia, melancholic depression and Parkinson’s disease. Brain Res. Bull. 70(4–6), 312–321 (2006).
  • Insel T, Cuthbert B, Garvey M et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am. J. Psychiatry 167(7), 748–751 (2010).
  • Williams LM, Rush AJ, Koslow SH et al. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol. Trials 12, 4 (2011).
  • de Winter RF, van Hemert AM, DeRijk RH et al. Anxious-retarded depression: relation with plasma vasopressin and cortisol. Neuropsychopharmacology 28(1), 140–147 (2003).
  • Sato T, Narita T, Hirano S, Kusunoki K, Sakado K, Uehara T. Is interpersonal sensitivity specific to non-melancholic depressions? J. Affect. Disord. 64(2–3), 133–144 (2001).
  • Withall A, Brodaty H, Altendorf A, Sachdev PS. A longitudinal study examining the independence of apathy and depression after stroke: the Sydney Stroke Study. Int. Psychogeriatr. 23(2), 264–273 (2011).
  • Michopoulos I, Zervas IM, Papakosta VM et al. Set shifting deficits in melancholic vs. non-melancholic depression: preliminary findings. Eur. Psychiatry 21(6), 361–363 (2006).
  • Rogers MA, Bradshaw JL, Phillips JG, Chiu E. Reliance on external cues during serial sequential movement in major depression. J. Neurol. Neurosurg. Psychiatr. 69(2), 237–239 (2000).
  • Angst J, Gamma A, Benazzi F, Ajdacic V, Rössler W. Melancholia and atypical depression in the Zurich study: epidemiology, clinical characteristics, course, comorbidity and personality. Acta Psychiatr. Scand. Suppl. 433, 72–84 (2007).
  • Hansen PE, Wang AG, Stage KB, Kragh-Sorensen P; Danish University Antidepressant Group. Comorbid personality disorder predicts suicide after major depression: a 10-year follow-up. Acta Psychiatr. Scand. 107(6), 436–440 (2003).
  • Rogers MA, Bradshaw JL, Phillips JG et al. Parkinsonian motor characteristics in unipolar major depression. J. Clin. Exp. Neuropsychol. 22(2), 232–244 (2000).
  • Frank E, Anderson B, Reynolds CF 3rd, Ritenour A, Kupfer DJ. Life events and the research diagnostic criteria endogenous subtype. A confirmation of the distinction using the Bedford College methods. Arch. Gen. Psychiatry 51(7), 519–524 (1994).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.